Methotrexate and Vinblastine or Vinorelbine Remain Useful Treatments for Desmoid-Type Fibromatosis 30 Years Later

被引：1
作者：
Schuetze, Scott M. [1 ]
机构：
[1] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
来源：
CANCER JOURNAL | 2017年 / 23卷 / 02期
关键词：
LOW-DOSE CHEMOTHERAPY; PHASE-II TRIAL; TUMORS; IMATINIB; THERAPY;
D O I：
10.1097/PPO.0000000000000250
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：92 / 94
页数：3
相关论文
共 15 条
  • [1] Azzarelli A, 2001, CANCER, V92, P1259, DOI 10.1002/1097-0142(20010901)92:5<1259::AID-CNCR1446>3.0.CO
  • [2] 2-Y
  • [3] Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial
    Chugh, Rashmi
    Wathen, J. Kyle
    Patel, Shreyaskumar R.
    Maki, Robert G.
    Meyers, Paul A.
    Schuetze, Scott M.
    Priebat, Dennis A.
    Thomas, Dafydd G.
    Jacobson, Jon A.
    Samuels, Brian L.
    Benjamin, Robert S.
    Baker, Laurence H.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (19) : 4884 - 4891
  • [4] Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment
    Fiore, Marco
    Rimareix, Francoise
    Mariani, Luigi
    Domont, Julien
    Collini, Paola
    Le Pechoux, Cecile
    Casali, Paolo G.
    Le Cesne, Axel
    Gronchi, Alessandro
    Bonvalot, Sylvie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (09) : 2587 - 2593
  • [5] Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
    Gounder, Mrinal M.
    Lefkowitz, Robert A.
    Keohan, Mary Louise
    D'Adamo, David R.
    Hameed, Meera
    Antonescu, Cristina R.
    Singer, Samuel
    Stout, Katherine
    Ahn, Linda
    Maki, Robert G.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (12) : 4082 - 4090
  • [6] Long-term outcomes for desmoid tumors treated with radiation therapy
    Guadagnolo, B. Ashleigh
    Zagars, Gunar K.
    Ballo, Matthew T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02): : 441 - 447
  • [7] A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral γ-Secretase Inhibitor PF-03084014
    Messersmith, Wells A.
    Shapiro, Geoffrey I.
    Cleary, James M.
    Jimeno, Antonio
    Dasari, Arvind
    Huang, Bo
    Shaik, M. Naveed
    Cesari, Rossano
    Zheng, Xianxian
    Reynolds, Jennifer M.
    English, Patricia A.
    McLachlan, Karen R.
    Kern, Kenneth A.
    LoRusso, Patricia M.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (01) : 60 - 67
  • [8] Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
    Penel, N.
    Le Cesne, A.
    Bui, B. N.
    Perol, D.
    Brain, E. G.
    Ray-Coquard, I.
    Guillemet, C.
    Chevreau, C.
    Cupissol, D.
    Chabaud, S.
    Jimenez, M.
    Duffaud, F.
    Piperno-Neumann, S.
    Mignot, L.
    Blay, J. -Y.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (02) : 452 - 457
  • [9] Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation
    Salas, Sebastien
    Dufresne, Armelle
    Bui, Binh
    Blay, Jean-Yves
    Terrier, Philippe
    Ranchere-Vince, Dominique
    Bonvalot, Sylvie
    Stoeckle, Eberhard
    Guillou, Louis
    Le Cesne, Axel
    Oberlin, Odile
    Brouste, Veronique
    Coindre, Jean-Michel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3553 - 3558
  • [10] Vinblastine and methotrexate for desmoid fibromatosis in children: Results of a Pediatric Oncology Group phase II trial
    Skapek, Stephen X.
    Ferguson, William S.
    Granowetter, Linda
    Devidas, Meenakshi
    Perez-Atayde, Antonio R.
    Dehner, Louis P.
    Hoffer, Fredric A.
    Speights, Roseanne
    Gebhardt, Mark C.
    Dahl, Gary V.
    Grier, Holcombe E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 501 - 506
12